Year
2023
-
CANbridge Pharmaceuticals Granted Orphan Drug Designation for CAN 106 for the Treatment of Myasthenia Gravis
-
Vistagen Announces Publication in Cells Demonstrating AV-101’s Potential for Treating Levodopa-Induced Dyskinesia in Patients with Parkinson’s Disease
-
FDA May Approve Naloxone for Nonprescription Use
-
FDA panel backs Ardelyx CKD drug, despite agency concerns
-
Novel AI blood test detects liver cancer
-
Camber Pharmaceuticals Launches Generic Lamictal XR
-
Tzield drug that can delay onset of type 1 diabetes has a pricetag close to $200,000
-
AbbVie Reaches $54.4 Million Settlement Over Its Alzheimer’s Drug
-
FDA Approves Second Interchangeable Insulin Product, Rezvoglar (insulin glargine-aglr)
-
Regeneron, CytomX announce bispecific therapeutics for cancer collab